Status:
COMPLETED
Study Evaluating the Etiology of Intra-Abdominal Infections
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Intra-abdominal Infection
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to define the etiology of intra-abdominal infections, to study the role of Enterococcus spp and Pseudomonas aeruginosa in these infections and to clarify the need for specific...
Eligibility Criteria
Inclusion
- A case will be defined as an intra-abdominal abscess or peritoneal fluid culture that will be positive for enterococcus or an enterococcal bacteriemia in association with an intra-abdominal source of infection.
- A control will be defined as a culture-positive intra-abdominal infection or bacteriemia due to an intraabdominal focus where enterococci have not been isolated.
Exclusion
- \-
Key Trial Info
Start Date :
April 1 2004
Trial Type :
OBSERVATIONAL
End Date :
December 1 2004
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT00244088
Start Date
April 1 2004
End Date
December 1 2004
Last Update
September 1 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.